Rising safety and quality demands fuel expansion of U.S. supplement testing
With the U.S. supplement market continuing to expand, manufacturers are under increasing pressure to substantiate claims.
With the U.S. supplement market continuing to expand, manufacturers are under increasing pressure to substantiate claims.
New policy changes have contributed to increased confusion, lower member satisfaction and a widespread lack of trust among Medicare Advantage plan members.
“Americans aren't pulling back yet, but tariffs have the potential to cause consumer behaviors to shift overnight,” said Bryan Gernert, CEO of Resonate.
Report also shows widespread concerns about inflation, highlighting the need for empathetic and responsive marketing strategies.
Home healthcare settings are projected to account for nearly one-third of RPM device demand in 2025.
Bupathi offers timely insights on the evolving pharmacy-PBM dynamic.
The U.S. market is also shaping global best practices, with homegrown RMN platforms influencing strategies in other regions.
New research reveals a significant gap between what beauty retailers think shoppers want and what they actually expect when they enter a store.
The pilot will assess program feasibility, patient nutrition security, clinical outcomes like A1c and blood pressure, and sustainability with health plan partners.
Pharmaceutical prices projected to rise 3.35%; supply chain prices, 2.41%.
New Hampshire has the lowest average monthly health-insurance premium, which is 2.5 times lower than in West Virginia, the highest.
Retailers saw signs of consumers holding out for deals as spending slowed in late June, as shoppers awaited July promotions.
Consumers have altered their spending behavior in response to these pressures, signaling a widespread realignment in how and where they shop.
Facts up Front is a voluntary, industry-led initiative that displays key nutrition data from the FDA-required Nutrition Facts panel on the front of food and beverage packaging.
GLP-1 inhibitors linked to reduced mortality and fewer cognitive problems after stroke and brain hemorrhage, according to three studies.
Prescription drug spending overall increased by 8% last year, with Mercer projecting a 5.8% rise in total health benefit costs for 2025.